![Figure displays a summary of the screening for chlamydial infection recommendations in table format. For a text of this table, go to the Clinical Summary [D].](chlrsfig1.jpg)
[D] Select for Text Description.
Notes: For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement, and supporting
documents, please go to http://www.preventiveservices.ahrq.gov/.
*Chlamydial infection results in few sequelae in men. Therefore, the major benefit of
screening men would be to reduce the likelihood that infected and untreated men would pass the infection to sexual partners. There is no evidence
that screening men reduces the long-term consequences of chlamydial infection in women. Because of this lack of evidence, the USPSTF could
not assess the balance of benefits and harms and concluded that the evidence is insufficient to recommend for or against routinely screening men.
†Information from reference 1.
AHRQ Publication No. 07-05101-EF-3